1801551-07-4
Chemical Structure
GnRH antagonist 1
Synonym(s): Relugolix impurity 1
- CAS No.: 1801551-07-4
- Formula:C28H25F2N7O5S
- Molecular Weight:609.61
IUPAC Name: 1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-2,4-dioxo-3-(6-oxo-1,6-dihydropyridazin-3-yl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea
InChIKey: DXPXBUAIEPOSBT-UHFFFAOYSA-N
SMILES: O=C1C=CC(=NN1)N2C(=O)C3=C(SC(C=4C=CC(=CC4)NC(=O)NOC)=C3CN(C)C)N(C2=O)CC=5C(F)=CC=CC5F
Biological Activity: GnRH antagonist 1 (Relugolix impurity 1) is a GnRH receptor antagonist that blocks the binding of gonadotropin-releasing hormone (GnRH) in the anterior pituitary, thereby inhibiting the secretion of luteinizing hormone and follicle-stimulating hormone. GnRH antagonist 1 can be used for research on endometriosis, uterine fibroids, and prostate cancer[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
GnRH antagonist 1 | GnRH antagonist 1 (Relugolix impurity 1) is a GnRH receptor antagonist that blocks the binding of gonadotropin-releasing hormone (GnRH) in the anterior pituitary, thereby inhibiting the secretion of luteinizing hormone and follicle-stimulating hormone. GnRH antagonist 1 can be used for research on endometriosis, uterine fibroids, and prostate cancer. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
